Tempus AI (TEM) Expected to Announce Earnings on Monday

Tempus AI (NASDAQ:TEM) is projected to issue its quarterly earnings data after the market closes on Monday, February 24th. Analysts expect the company to announce earnings of ($0.15) per share and revenue of $202.80 million for the quarter.

Tempus AI Trading Down 10.5 %

TEM opened at $76.72 on Friday. Tempus AI has a 12 month low of $22.89 and a 12 month high of $91.45. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The stock has a 50-day moving average of $49.75 and a 200 day moving average of $51.44.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on TEM. Wolfe Research began coverage on shares of Tempus AI in a research note on Friday, December 13th. They set an “outperform” rating and a $60.00 price target for the company. William Blair downgraded shares of Tempus AI from an “outperform” rating to a “market perform” rating in a research note on Wednesday, February 12th. Bank of America lifted their price target on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a report on Friday, December 13th. Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and boosted their price objective for the company from $45.00 to $65.00 in a report on Monday, November 11th. Finally, Loop Capital dropped their price objective on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a report on Tuesday, January 14th. Four investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $58.55.

Insiders Place Their Bets

In other Tempus AI news, EVP Andrew Polovin sold 51,504 shares of the firm’s stock in a transaction dated Wednesday, December 11th. The stock was sold at an average price of $42.39, for a total value of $2,183,254.56. Following the transaction, the executive vice president now directly owns 246,085 shares of the company’s stock, valued at $10,431,543.15. This trade represents a 17.31 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jennifer A. Doudna sold 1,320 shares of the firm’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $90.00, for a total value of $118,800.00. Following the sale, the director now owns 36,011 shares of the company’s stock, valued at $3,240,990. This represents a 3.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 2,583,467 shares of company stock worth $130,542,311.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.